Cala’s Real-World Study Validates its Wearable’s Long-Term Efficacy

Posted on October 5, 2022

Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced patients’ tremor power by 71%. The Burlingame, California-based company was founded in 2014 as a Stanford University spinout. It makes a wrist-based wearable that uses electrical stimulation to temporarily relieve tremor symptoms.

4 thoughts on “Cala’s Real-World Study Validates its Wearable’s Long-Term Efficacy

  1. I would like to know how I go about getting a Cala Trio to treat my ET. I am becoming increasing unable to write, and eating and drinking has been a problem to do it in tidy fashion. My medications do not seem to touch my tremors on some days, at all. I am 67 years old, and have had ET for over 30 years.

Comments are closed.